Toward improved in vitro models of human cancer
Open accessThe DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Cancer is a leading cause of death across the world and continues to increase in incidence. Despite years of research, multiple tumors (e.g., glioblastoma, pancreatic cancer) still have limited treatment options in the clinic. Additionally, the attrition rate and cost of drug development have continued to increase. This trend is partly explained by the poor predictive power of traditional in vitro tools and animal models. Moreover, multiple studies have highlighted that cell culture in traditional Petri dishes commonly fail to predict drug sensitivity. Conversely, animal models present differences in tumor biology compared with human pathologies, explaining why promising therapies tested in animal models often fail when tested in humans. The surging complexity of patient management with the advent of cancer vaccines, immunotherapy, and precision medicine demands more robust and patient-specific tools to better inform our understanding and treatment of human cancer. Advances in stem cell biology, microfluidics, and cell culture have led to the development of sophisticated bioengineered microscale organotypic models (BMOMs) that could fill this gap. In this Perspective, we discuss the advantages and limitations of patient-specific BMOMs to improve our understanding of cancer and how these tools can help to confer insight into predicting patient response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as Ayuso et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Physics and Applications of Microfluidics in Biology
Beebe, D. J., Mensing, G. A., & Walker, G. M. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.112601.125916 · Cited by 1,800
Self-citationCollagen density promotes mammary tumor initiation and progression
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Knittel, J. G., Yan, L., Rueden, C. T., White, J. G., & Keely, P. J. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-11 · Cited by 1,361
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Lee, C.-Y., Chang, C.-L., Wang, Y.-N., & Fu, L.-M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053263 · Cited by 1,111
Research works printed but not linked: 3
- 6. Folch A., Introduction to BioMEMS (CRC Press, 2016).
- 96. Grego S. et al., Systems Biology for Organotypic Cell Cultures (Lawrence Livermore National Lab (LLNL)/Los Alamos National Lab (LANL), Livermore, CA, USA/Los Alamos, NM, USA, 2016).
- 101. U.S. Environmental Protection Agency, Office of Research and Development, Organotypic Culture Models for Predictive Toxicology Research Centers (U.S. Environmental Protection Agency, Office of Research and Development, 2015).
Cited by
Letai, A., Bhola, P., & Welm, A. L. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.004 · Cited by 281
A role for microfluidic systems in precision medicine
Ayuso, J. M., Virumbrales-Muñoz, M., Lang, J. M., & Beebe, D. J. (2022) · Nature Communications · doi:10.1038/s41467-022-30384-7 · Cited by 216
Self-citationCurrent insights into the bone marrow niche: From biology in vivo to bioengineering ex vivo
Xiao, Y., McGuinness, C. S., Doherty-Boyd, W. S., Salmerón‐Sánchez, M., Donnelly, H., & Dalby, M. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121568 · Cited by 72
Simitian, G. S., Virumbrales-Muñoz, M., Sánchez‐de‐Diego, C., Beebe, D. J., & Kosoff, D. (2022) · Lab on a Chip · doi:10.1039/d2lc00352j · Cited by 56
Self-citationLugo-Cintrón, K. M., Ayuso, J. M., Humayun, M., Gong, M. M., Kerr, S. C., Ponik, S. M., Harari, P. M., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103634 · Cited by 45
Self-citationMacaraniag, C., Luan, Q., Zhou, J., & Papautsky, I. (2022) · APL Bioengineering · doi:10.1063/5.0093806 · Cited by 50
Microphysiological systems for solid tumor immunotherapy: opportunities and challenges
Abizanda-Campo, S., Virumbrales-Muñoz, M., Humayun, M., Mármol, I., Beebe, D. J., Ochoa, I., Oliván, S., & Ayuso, J. M. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00616-x · Cited by 47
Self-citationOn-chip recapitulation of the tumor microenvironment: A decade of progress
Giannitelli, S. M., Peluzzi, V., Raniolo, S., Roscilli, G., Trombetta, M., Mozetic, P., & Rainer, A. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122482 · Cited by 45
In Vitro Cancer Models: A Closer Look at Limitations on Translation
Antunes, N., Kundu, B., Kundu, S. C., Reis, R. L., & Correlo, V. M. (2022) · Bioengineering · doi:10.3390/bioengineering9040166 · Cited by 45
Templeton, A. R., Jeffery, P. L., Thomas, P. B., Perera, O. M., Ng, G. K. H., Calabrese, A. R., Nicholls, C., Mackenzie, N. J., Wood, J., Bray, L. J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.767697 · Cited by 33
Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics
Shapiro, D. D., Virumbrales-Muñoz, M., Beebe, D. J., & Abel, E. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.871252 · Cited by 28
Self-citationAdvances in exercise-induced vascular adaptation: mechanisms, models, and methods
Sun, H., Zhang, Y., & Shi, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1370234 · Cited by 33
Microphysiological model of renal cell carcinoma to inform anti-angiogenic therapy
Virumbrales-Muñoz, M., Ayuso, J. M., Loken, J. R., Denecke, K. M., Rehman, S., Skala, M. C., Abel, E. J., & Beebe, D. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121454 · Cited by 20
Self-citationEngineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
Nam, H., Choi, Y., Cho, S., Gao, G., Kim, D., Kim, J., Choi, H., Lee, S., & Jang, J. (2022) · Biofabrication · doi:10.1088/1758-5090/ac93b6 · Cited by 20
Wang, J., Wu, Y., Liu, K., Yang, W., Zeng, W., Gao, X., Liu, S., & Zhang, B. (2023) · APL Bioengineering · doi:10.1063/5.0139929 · Cited by 19
Richi, R. R., AlSawaftah, N., & Husseini, G. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31402 · Cited by 23
In Vitro Human Cancer Models for Biomedical Applications
Choi, J. R., Kozalak, G., di Bari, I., Babar, Q., Niknam, Z., Rasmi, Y., & Yong, K. W. (2022) · Cancers · doi:10.3390/cancers14092284 · Cited by 17
Microfluidic Model to Evaluate Astrocyte Activation in Penumbral Region following Ischemic Stroke
Denecke, K. M., Reed-McBain, C. A., Hermes, B. G., Teertam, S. K., Farooqui, M. A., Virumbrales-Muñoz, M., Panackal, J. E., Beebe, D. J., Famakin, B. M., & Ayuso, J. M. (2022) · Cells · doi:10.3390/cells11152356 · Cited by 16
Self-citationSadangi, S., Milosavljevic, K., Castro‐Pérez, E., Lares, M., Singh, M. K., Altameemi, S., Beebe, D. J., Ayuso, J. M., & Setaluri, V. (2022) · Cancers · doi:10.3390/cancers14051233 · Cited by 15
Self-citationAyuso, J. M., Farooqui, M. A., Virumbrales-Muñoz, M., Denecke, K., Rehman, S., Schmitz, R. L., Guerrero, J. F., Sánchez‐de‐Diego, C., Abizanda-Campo, S., Maly, E. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41625-8 · Cited by 15
Self-citationZhang, D., Yang, J., Hirai, Y., Kamei, K., Tabata, O., & Tsuchiya, T. (2022) · Japanese Journal of Applied Physics · doi:10.35848/1347-4065/aca265 · Cited by 10
Research Progress in the Construction and Application of In Vitro Vascular Models
He, Z., Cheng, P., Ying, G., & Ou, Z. (2024) · Applied Sciences · doi:10.3390/app14156780 · Cited by 8
Toward improved models of human cancer: Two perspectives
Kamm, R. D. (2021) · APL Bioengineering · doi:10.1063/5.0042324 · Cited by 7
Sibbitts, J., Pietro, L. D., Privitera, A., Cardaci, V., Maugeri, S., Camarda, M., & Caruso, G. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673298382240307040239 · Cited by 6
Occupational exposure to mixtures and toxic pathways prediction for workers’ health
Rim, K.-T. (2022) · Molecular & Cellular Toxicology · doi:10.1007/s13273-022-00306-1 · Cited by 4
Mechanobiology of Collective Cell Migration in 3D Microenvironments
Hruska, A. M., Yang, H., Leggett, S. E., Guo, M., & Wong, I. Y. (2012) · Current cancer research · doi:10.1007/978-3-031-22802-5_1 · Cited by 3
Horowitz, L. F., Rodríguez‐Mias, R. A., Chan, M., Zhu, S., Tang, Y., Locke, A., Gottshall, N. R., Stepanov, I., Stiles, C., Yeung, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.22.586189 · Cited by 3
Coupling Micro-Physiological Systems and Biosensors for Improving Cancer Biomarkers Detection
Brancato, V., Reis, R. L., & Kundu, S. C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_12 · Cited by 2
An overview of graphene-based sensors for organ-on-a-chip systems
Ouedraogo, L. J. G., Kling, M., & Hashemi, N. N. (2025) · Innovation and Emerging Technologies · doi:10.1142/s2737599425300028 · Cited by 1
Hecking, J., Cano-Jorge, M., Passier, R., & Rivera-Arbeláez, J. M. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1719533
“While 2D models offer high throughput and simplicity, they fail to replicate physiological complexity (Ayuso et al., 2021).”
Metal complexes as chemotherapeutic agents
Deo, K. M., & Aldrich-Wright, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823144-9.00050-9
Therapeutic Molecular Targets of Cancer and Animal Models: Adequacy and Drawbacks
Hriţcu, L., & Cioancă, O. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_42-1
Editorial Series conclusion and journal outlook
Cooper-White, J. J. (2022) · APL Bioengineering · doi:10.1063/5.0105711
Mimicking Mechanical Features of the Tumor Microenvironment
Mierke, C. T. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00060
Therapeutic Molecular Targets of Cancer and Animal Models: Adequacy and Drawbacks
Hriţcu, L., & Cioancă, O. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_42
Chakraborty, S., Nair, J. M., & Bharadwaj, D. (2024) · RNA technologies · doi:10.1007/978-3-031-62178-9_14
Alternatives to Animal Testing and the Future of Preclinical Research
Parasuraman, S., Kamini, V., & Sam, A. T. (2026) · Springer eBooks · doi:10.1007/978-981-92-0038-2_14
New insights in tumor-on-a-chip models for studying cancer drug resistance
Wang, Y., Shi, L., Li, J., Zhang, X., Ren, J., Jia, Q., Lv, L., Yang, L., Zhang, Z., Yang, J., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156562
Laminin – myCAF interplay promotes α6-integrin-mediated breast cancer cell invasion
Virumbrales-Muñoz, M., Fertal, S. A., Lugo-Cintrón, K. M., Loken, J. R., Vazquez, Y. N., Burkel, B. M., Zhang, J., Franck, C., Ayuso, J. M., Beebe, D. J., et al. (2026) · Lab on a Chip · doi:10.1039/d5lc00711a
Self-citation
Metadata
- Authors
- Ayuso, J. M., Park, K.-Y., Virumbrales-Muñoz, M., & Beebe, D. J.
- Affiliations
- Department of Biomedical Engineering, University of Wisconsin 1 , Madison, Wisconsin 53705, USA
- University of California, San Francisco (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Beebe, David J.
- Venue
- APL Bioengineering
- Publisher
- AIP Publishing
- Published
- 2021-01-21
- Volume
- 5
- Issue
- 1
- Pages
- 010902-010902
- ISSN
- 2473-2877 (ISSN-L)
- PMC
- PMC7822630
- OpenAlex
- W3122854086
- Cited by
- 40
- References
- 96
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 7 · 2023: 5 · 2022: 18 · 2021: 4
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- APL Bioengineering (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wisconsin Head and Neck Cancer SPORE (P50DE026787)
- Morgridge Institute for Research (-)
- National Cancer Institute (R01EB010039, 5T32HL110853-07)
- University of Wisconsin Carbone Cancer Center (P30CA014520)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- in vitro tumor model, drug response prediction, translational oncology, microfluidics, glioblastoma, pancreatic cancer, precision medicine, cancer immunotherapy, cancer vaccines, drug development attrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.